NO166187C - Fremgangsmaate for fremstilling av naturlig heparansulfat og dermatansulfat i hovedsakelig ren form. - Google Patents

Fremgangsmaate for fremstilling av naturlig heparansulfat og dermatansulfat i hovedsakelig ren form.

Info

Publication number
NO166187C
NO166187C NO860940A NO860940A NO166187C NO 166187 C NO166187 C NO 166187C NO 860940 A NO860940 A NO 860940A NO 860940 A NO860940 A NO 860940A NO 166187 C NO166187 C NO 166187C
Authority
NO
Norway
Prior art keywords
sulphate
dermatan
pure form
procedure
preparation
Prior art date
Application number
NO860940A
Other languages
English (en)
Norwegian (no)
Other versions
NO860940L (no
NO166187B (no
Inventor
Rinaldo Del Bono
Luigi De Ambrosi
Piergiuseppe Pagella
Gianni Ferrari
Original Assignee
Mediolanum Farmaceutici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Farmaceutici Srl filed Critical Mediolanum Farmaceutici Srl
Publication of NO860940L publication Critical patent/NO860940L/no
Publication of NO166187B publication Critical patent/NO166187B/no
Publication of NO166187C publication Critical patent/NO166187C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0066—Isolation or extraction of proteoglycans from organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
NO860940A 1985-03-13 1986-03-12 Fremgangsmaate for fremstilling av naturlig heparansulfat og dermatansulfat i hovedsakelig ren form. NO166187C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8519885A IT1208509B (it) 1985-03-13 1985-03-13 Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico.

Publications (3)

Publication Number Publication Date
NO860940L NO860940L (no) 1986-09-15
NO166187B NO166187B (no) 1991-03-04
NO166187C true NO166187C (no) 1991-06-12

Family

ID=11162062

Family Applications (1)

Application Number Title Priority Date Filing Date
NO860940A NO166187C (no) 1985-03-13 1986-03-12 Fremgangsmaate for fremstilling av naturlig heparansulfat og dermatansulfat i hovedsakelig ren form.

Country Status (20)

Country Link
US (1) US4783447A (it)
EP (1) EP0199033B1 (it)
JP (1) JPS61218601A (it)
KR (1) KR910006809B1 (it)
AT (1) ATE99702T1 (it)
AU (1) AU582221B2 (it)
CA (1) CA1286286C (it)
DE (1) DE3689493T2 (it)
DK (1) DK113886A (it)
ES (1) ES8705894A1 (it)
FI (1) FI82700C (it)
GR (1) GR860677B (it)
IN (1) IN163616B (it)
IT (1) IT1208509B (it)
NO (1) NO166187C (it)
NZ (1) NZ215435A (it)
PH (2) PH22370A (it)
PT (1) PT82198B (it)
YU (1) YU46303B (it)
ZA (1) ZA861855B (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1189085B (it) * 1986-03-25 1988-01-28 Mediolanum Farmaceutici Srl Processo per la preparazione di dermatan solfato ad alta purezza e composizioni farmaceutiche che lo contengono
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
DE3639561A1 (de) * 1986-11-20 1988-06-01 Baumann Hanno Verfahren zur herstellung von nicht-thrombogenen substraten
IT1232939B (it) * 1987-11-06 1992-03-10 Opocrin Spa Eparan solfato caratterizzato da elevata attivita' antitrombotica, elevata biodisponibilita', assenza di attivita' anticoagulante; suo processo di estrazione da organi e da tessuti e relative composizioni farmaceutiche
MC2098A1 (fr) * 1988-06-03 1991-02-15 Italfarmaco Spa Sels de glycosaminoglycanes,procedes pour leur preparation et compositions pharmaceutiques les contenant
EP0421508B1 (en) * 1989-10-04 1993-12-15 Akzo Nobel N.V. Sulphated glycosaminoglycuronan with antithrombotic activity
WO1991006303A1 (en) * 1989-10-27 1991-05-16 Case Western Reserve University Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans
IT1240615B (it) * 1990-04-03 1993-12-17 Mediolanum Farmaceutici Spa Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale
WO1991015217A1 (en) * 1990-04-06 1991-10-17 Washington University Anticoagulant oligosaccharides
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
FR2691066B1 (fr) * 1992-05-15 1995-06-09 Sanofi Elf Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies.
IT1256236B (it) * 1992-12-23 1995-11-29 Mediolanum Farmaceutici Srl Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani
US5801162A (en) * 1993-09-30 1998-09-01 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Dermatan sulfate compositions and antithrombotic compositions containing same
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
IT1296581B1 (it) * 1997-11-28 1999-07-14 Istituto Scient Di Chimica E B Materiali polimerici non trombogenici e ad esaltata compatibilita' con fluidi e tessuti organici
AU782661B2 (en) * 1999-06-30 2005-08-18 Hamilton Civic Hospitals Research Development, Inc. Heparin compositions that inhibit clot associated coagulation factors
CZ2003961A3 (cs) * 2000-09-08 2003-10-15 Hamilton Civic Hospitals Research Development, Inc. Farmaceutický prostředek k inhibici nebo prevenci tvorby či aktivity thrombinu
CN107098989A (zh) * 2017-04-27 2017-08-29 甘肃省金羚集团药业有限公司 一种肝素钠的制备方法
CN114478832B (zh) * 2022-02-14 2023-03-03 河北常山生化药业股份有限公司 从肝素钠副产物中提纯四种多糖类产品的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3179566A (en) * 1963-05-16 1965-04-20 Canada Packers Ltd Purification of heparin
JPS5318520B2 (it) * 1972-07-05 1978-06-15
AR207237A1 (es) * 1974-02-25 1976-09-22 Thomas A Procedimiento para obtener extractos biologicos estables liofilizados solubles constituidos por complejos proteicos termorresistentes
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
JPS58171403A (ja) * 1982-04-01 1983-10-08 Eisai Co Ltd ヘパラン硫酸の精製法
IT1189298B (it) * 1982-06-18 1988-02-04 Manetti & Roberts Italo Brit Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico
FR2555993B1 (fr) * 1983-12-06 1986-11-07 Anic Spa Chitosanes 6-sulfates et procede pour leur preparation
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
IT1163772B (it) * 1983-07-13 1987-04-08 Baldacci Lab Spa Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
IT8519885A0 (it) 1985-03-13
CA1286286C (en) 1991-07-16
DK113886A (da) 1986-09-14
PT82198A (en) 1986-04-01
KR860007278A (ko) 1986-10-10
EP0199033B1 (en) 1994-01-05
AU582221B2 (en) 1989-03-16
NO860940L (no) 1986-09-15
NO166187B (no) 1991-03-04
FI82700C (fi) 1991-04-10
JPS61218601A (ja) 1986-09-29
ES552898A0 (es) 1987-05-16
US4783447A (en) 1988-11-08
GR860677B (en) 1986-07-14
IT1208509B (it) 1989-07-10
YU46303B (sh) 1993-05-28
PH22370A (en) 1988-08-12
ATE99702T1 (de) 1994-01-15
PH25136A (en) 1991-02-19
AU5472786A (en) 1986-09-18
NZ215435A (en) 1989-01-06
ES8705894A1 (es) 1987-05-16
KR910006809B1 (ko) 1991-09-02
DK113886D0 (da) 1986-03-12
IN163616B (it) 1988-10-15
FI861020A0 (fi) 1986-03-12
JPH0238601B2 (it) 1990-08-31
FI861020A (fi) 1986-09-14
YU37586A (en) 1988-04-30
EP0199033A2 (en) 1986-10-29
ZA861855B (en) 1986-10-29
DE3689493D1 (de) 1994-02-17
PT82198B (pt) 1988-02-17
DE3689493T2 (de) 1994-04-28
FI82700B (fi) 1990-12-31
EP0199033A3 (en) 1988-03-30

Similar Documents

Publication Publication Date Title
NO166187C (no) Fremgangsmaate for fremstilling av naturlig heparansulfat og dermatansulfat i hovedsakelig ren form.
ATE81672T1 (de) Ein durch xanthomonas hergestelltes polysaccharidpolymer.
NZ333925A (en) Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
CA2253833A1 (en) Derivatives of k5 polysaccharide having high anticoagulant activity
DE68921633D1 (de) Oligosaccharide mit antiatherosclerotischer wirkung.
IT1290814B1 (it) Glicosaminoglicani aventi elevata attivita' antitrombotica
MX9702362A (es) Metodo de produccion de productos de descomposicion de almidon.
IT1189298B (it) Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico
DE68914236D1 (de) Verfahren zur Herstellung von Natriumhyaluronat durch Gärung.
KR910007532A (ko) 항트롬보 활성을 지닌 설페이트화 글리코 사미노글리큐로난
IE902276L (en) Serpin variants
ATE332706T1 (de) Verwendung von hyaluronidase zur herstellung eines arzneimittels zur behandlung von entzündungen
ATE261438T1 (de) Produkte für körperhygiene basierend auf lapacho extrakte enthaltend quercetin, deren herstellung und verwendung
CA2348767A1 (en) Method for producing an antitumoral agent and antitumoral agent thus obtained
DE3885012D1 (de) Fermentationsverfahren zur Herstellung eines Polysaccharids wie Xanthan.
HUT53912A (en) New process for producing disaccharid -octasulfate- aluminium-complexes and their hydrates
ES2163023T3 (es) Derivados del 2-azabiciclo(2.2.1)heptano, su preparacion y su aplicacion.
IT1178041B (it) Uso dell'acido ialuronico come veicolo per farmaci oftalmici e composizioni farmaceutiche contenenti questa sostanza